Testing of chloroquine and quinacrine for mutagenicity in Drosophila melanogaster

Mutation Research
|December 1, 1985
PubMed

Insights

Chloroquine and quinacrine, both intercalating agents, significantly increased sex-linked recessive lethals in Drosophila melanogaster. However, neither compound induced sex-chromosome loss in male germ cells during the study.

Area of Science:

  • Genetics and Molecular Biology
  • Toxicology and Mutagenesis

Background:

  • Intercalating agents are known to interact with DNA, potentially causing mutations.
  • Data on the mutagenic effects of specific intercalating agents like chloroquine and quinacrine in Drosophila melanogaster needed further extension.

Purpose of the Study:

  • To investigate the mutagenic potential of chloroquine and quinacrine in Drosophila melanogaster.
  • To assess the induction of genetic damage, specifically sex-linked recessive lethals and sex-chromosome loss, by these intercalating agents.

Main Methods:

  • Adult male Drosophila melanogaster were treated with chloroquine and quinacrine via a feeding technique.
  • The frequency of sex-linked recessive lethals was quantified.
  • The induction of sex-chromosome loss was assessed.

Main Results:

  • Both chloroquine and quinacrine significantly increased the frequency of sex-linked recessive lethals.
  • Neither compound demonstrated the ability to induce sex-chromosome loss in male germ cells under the tested conditions.

Conclusions:

  • Chloroquine and quinacrine exhibit mutagenic activity by inducing sex-linked recessive lethals in Drosophila melanogaster.
  • These intercalating agents do not appear to cause sex-chromosome loss in male germ cells of this model organism.

Related Concept Videos